[Interpretation of the mechanism of the monoamine barrier in the cerebral capillaries].
D000588:Amines / Q000378:metabolism*; D000818:Animals; D001812:Blood-Brain Barrier / Q000187:drug effects*; D001921:Brain / Q000098:blood supply* / Q000187:drug effects / Q000378:metabolism; D001923:Brain Chemistry / Q000187:drug effects; D002199:Capillary Permeability / Q000187:drug effects; D002395:Catecholamines / Q000008:administration & dosage / Q000494:pharmacology*; D004027:Diencephalon / Q000098:blood supply; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage; D004298:Dopamine / Q000008:administration & dosage; D005260:Female; D006651:Histocytochemistry; D007274:Injections, Intraperitoneal; D008297:Male; D051379:Mice; D009526:Nialamide / Q000008:administration & dosage; D010433:Pentylenetetrazole / Q000008:administration & dosage; D012110:Reserpine / Q000008:administration & dosage
D000588:Amines; D002395:Catecholamines; D004295:Dihydroxyphenylalanine; D012110:Reserpine; D009526:Nialamide; D004298:Dopamine; D010433:Pentylenetetrazole
Adatok az agyi capillarisok monoamin-barrier mechanismusának értelmezéséhez